Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,280 | -9,129 | -100,606 | -92,257 | -88,355 |
| Depreciation Amortization | 460 | 253 | 159 | -5 | N/A |
| Accounts payable and accrued liabilities | 580 | 121 | 557 | -149 | 741 |
| Other Working Capital | 2,720 | -41 | 298 | -3,774 | 311 |
| Other Operating Activity | 753 | 497 | 81,631 | 81,863 | 80,669 |
| Operating Cash Flow | $-14,767 | $-8,299 | $-17,961 | $-14,322 | $-6,634 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,731 | -5,090 | -104,080 | -94,095 | N/A |
| PPE Investments | -45 | -9 | -40 | -14 | -6 |
| Investing Cash Flow | $3,686 | $-5,099 | $-104,120 | $-94,109 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17 | N/A | 169,185 | 169,175 | 614 |
| Other Financing Activity | -31 | 0 | 31,281 | 31,281 | 31,061 |
| Financing Cash Flow | $-14 | $N/A | $200,466 | $200,456 | $31,675 |
| Beginning Cash Position | 122,162 | 122,162 | 43,777 | 43,777 | 43,777 |
| End Cash Position | 111,067 | 108,764 | 122,162 | 135,802 | 68,812 |
| Net Cash Flow | $-11,095 | $-13,398 | $78,385 | $92,025 | $25,035 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,767 | -8,299 | -17,961 | -14,322 | -6,634 |
| Capital Expenditure | -45 | -9 | -40 | -14 | -6 |
| Free Cash Flow | -14,812 | -8,308 | -18,001 | -14,336 | -6,640 |